This year's ViVE conference was full of announcements — from acquisitions to rebrands to product launches. This list compiles short summaries for seven of the conference’s most notable announcements.

This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did ...

The serial entrepreneur and CEO of Transcarent has dismissed care navigation companies in the past. What led him to buy ...

House Republicans introduced a proposal seeking to cut Medicaid spending by hundreds of billions of dollars. Healthcare ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

The Senate confirmed Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services. Healthcare leaders ...

Lynx, a fintech platform for healthcare payments, has raised $27 million in Series A funding to scale its operations, the company recently announced. Boston-based Lynx works with health plans ...

The obesity drugs currently available address a broad swath of patients who struggle to manage their weight. While Aardvark Therapeutics is interested in serving this market, first it wants to ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

Vertex Pharmaceuticals dominates the market for cystic fibrosis drugs, but Sionna Therapeutics contends the pharma company’s products still have efficacy and safety limitations. Sionna has ...

In the past couple years, AI-powered ambient documentation tools have done a commendable job at reducing clinicians’ administrative burden — and the initial success of these tools points to a ...

There is both a health case and a business case for why a balanced diet is important. Lack of good nutrition is the number one driver of poor health outcomes in the U.S. And suboptimal diets ...